RCE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.424400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.041400E-01
Normal-vs-Stage2
2.909800E-01
Normal-vs-Stage3
8.763800E-01
Normal-vs-Stage4
6.073800E-02
Stage1-vs-Stage2
2.857400E-01
Stage1-vs-Stage3
6.175600E-01
Stage1-vs-Stage4
2.142000E-01
Stage2-vs-Stage3
1.609180E-01
Stage2-vs-Stage4
8.872000E-01
Stage3-vs-Stage4
1.843020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.679200E-01
Normal-vs-AfricanAmerican
3.268800E-01
Normal-vs-Asian
1.019160E-01
Caucasian-vs-AfricanAmerican
8.598400E-01
Caucasian-vs-Asian
6.367200E-01
AfricanAmerican-vs-Asian
6.002400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.764600E-01
Normal-vs-Female
4.493600E-01
Male-vs-Female
2.451600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.839000E-01
Normal-vs-Age(41-60Yrs)
1.591620E-01
Normal-vs-Age(61-80Yrs)
4.973600E-01
Normal-vs-Age(81-100Yrs)
1.973030E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.854200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.316600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.968200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.152060E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.834000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.862000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.766200E-01
Normal-vs-Daily Drinker
1.515960E-01
Normal-vs-Weekly Drinker
2.727200E-01
Normal-vs-Occasional Drinker
6.473900E-02
Normal-vs-Social Drinker
4.595800E-01
Non Drinker-vs-Daily Drinker
1.173720E-02
Non Drinker-vs-Weekly Drinker
4.470200E-01
Non Drinker-vs-Occasional Drinker
6.078900E-03
Non Drinker-vs-Social Drinker
4.036800E-01
Daily Drinker-vs-Weekly Drinker
1.304580E-01
Daily Drinker-vs-Occasional Drinker
9.870000E-01
Daily Drinker-vs-Social Drinker
3.315600E-01
Weekly Drinker-vs-Occasional Drinker
6.877700E-02
Weekly Drinker-vs-Social Drinker
7.532400E-01
Occasional Drinker-vs-Social Drinker
2.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.253800E-01
Normal-vs-Grade 2
2.904800E-01
Normal-vs-Grade 3
1.534810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.738900E-03
Grade 1-vs-Grade 3
8.02779999999892E-05
Grade 1-vs-Grade 4
8.253800E-01
Grade 2-vs-Grade 3
9.036200E-02
Grade 2-vs-Grade 4
2.904800E-01
Grade 3-vs-Grade 4
1.534810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.277800E-01
Normal-vs-NonDiabetic
2.417800E-01
Diabetic-vs-NonDiabetic
1.195380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.836000E-02
Normal-vs-NoPancreatitis
3.389200E-01
Pancreatitis-vs-NoPancreatitis
3.656000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.437400E-01
Normal-vs-N1
3.309200E-01
N0-vs-N1
6.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.758200E-02
Normal-vs-TP53-NonMutant
9.828200E-01
TP53-Mutant-vs-TP53-NonMutant
1.25260002370453E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
